DOCSLIB.ORG

Annual General Meeting

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual General Meeting ANNUAL GENERAL MEETING The ANNUAL GENERAL MEETING of the British Thoracic Society will be held on Wednesday 2nd December 2020 at 4:30PM virtually on Zoom. Please register in advance via Zoom: https://zoom.us/webinar/register/WN_FREtv- O6SYeHAq-FBBfXNw It would be fair to say that the BTS Strategic Plan highlighted in the 2019 AGM papers and Annual Report and aligned to the 4 UK Nations’ Health Plans, took a step back in 2020 due to the unprecedented challenges that the COVID-19 pandemic placed upon the global population and global healthcare. Specifically, this presented both the British public and our healthcare systems with huge challenges at all levels. Respiratory medicine, BTS and its members have stepped up to this task with impressive innovation, dedication, hard graft and positivity. BTS is, and has been, one of the premier sources of guidance on the management of COVID-19 with a dedicated website hosting BTS guidance, as well as information from government sources across the four nations and allied specialist societies. The webpages have been, and continue to be, viewed hundreds of thousands of times. We are all aware that we are not out of the fire by any stretch and the prospect of managing “endemic” acute COVID-19, COVID-19 follow up including “Post COVID-19 Syndrome” together with seasonal “Winter pressures” allied to our “usual” population of patients with respiratory disease is going to remain challenging. As with the general population, this has not been without a physical and emotional cost, with many of our members being infected and suffering stress, anxiety and potential burnout. However, the respiratory community continues to remain highly resilient, adaptable and motivated, providing the highest possible care for our patients. More than ever, BTS continues to strive to be more effective in pursuit of our objectives for patient benefit, by:- finding ways of unifying the professional and patient voice within our structures; promoting awareness of the respiratory workforce and how it contributes to patient care and innovation in delivery across the patient pathway; promoting awareness of respiratory disease and its significant impacts on health outcomes, mortality and health inequalities; producing world-class clinical standards and related quality improvement tools; seeking more effective synergies with others; promoting equality of opportunity and outcomes in all that we do; developing effective communication and engagement systems. We have used the threat of the pandemic to realise opportunities for increased advocacy, implementing synergies with other bodies, and conducting the business and educational events of the BTS virtually. The Officers, HQ staff and I would like to thank all of our members for their unstinting hard work and dedication during this past tumultuous year. Members who were actively involved in planning, delivering and evaluating the effectiveness of what we do are listed on the inside back cover of this booklet. Jon Bennett Chair of the BTS Board of Trustees 2 BRITISH THORACIC SOCIETY ANNUAL GENERAL MEETING Wednesday 2nd December 2020 at 4.30pm by Zoom Please register in advance via https://zoom.us/webinar/register/WN_FREtv-O6SYeHAq-FBBfXNw After registering, you will receive a confirmation email containing more information about joining the AGM. Please send apologies to [email protected] A G E N D A The Society’s President, Dr Mohammed Munavvar, will be in the Chair. 1. Apologies for absence 2. Minutes of the Annual General Meeting (AGM) held on Wednesday 4th December 2019 (Paper 1) 3. Matters arising from the minutes if not elsewhere on the agenda 4. Report from the Chair of the Board of Trustees Members are referred also to the Annual Report from the Board of Trustees which can be found here: https://www.brit-thoracic.org.uk/about-us/governance-documents-and- policies/ 4.1 Professor Jon Bennett will give a brief overview of activities during the year. He will focus on the Society and the speciality’s work in relation to COVID-19 in pandemic and endemic stages, re-setting and follow-up respiratory services; the Board’s revision of BTS strategy for the coming 3 years; and changes in BTS head office staffing and structure. 5. Report from the Honorary Treasurer 5.1 Report and financial statements for the period ended 30 June 2020 (Paper 2) 5.2 Investments 5.3 Membership Fees for 2021, including the raising by ERS of the annual fee for ERS membership from £20 to £30 a year. 5.4 Revision of membership administration arrangements. 5.5 Delegate rates for Meetings in 2021 5.6 Appointment of auditors for 2020/2021 6. Report from Editors of Thorax and British Open Respiratory Research (BORR) 6.1 The annual reports from the Editors-in-Chief are enclosed (Papers 3a and 3b) 3 7 Office Bearers and Trustees 7.1 President and President-elect 2021 The Honorary Secretary will report. Following the call for nominations in the summer of 2020, Rachel Moses was nominated and was returned unopposed. She will serve as President-elect with effect from December 2020, serving as President for one year from November 2021. Dr Graham Burns will serve as President in 2021. 7.2 Chair of BTS Board The post of Chair is advertised in the year before the current incumbent demits office, as required by the Society’s constitution. This allows for effective handover to take place during the coming year. Following advertisement in the summer of 2020, interviews took place in October. The Board is pleased to announce that Dr Paul Walker will take over as Chair of the BTS Board in November 2021, serving for three years until November 2024. 7.3 Honorary Treasurer Dr John Park will succeed Dr Paul Walker as Hon. Treasurer with effect from the AGM, serving until November 2023. 7.4 Trustee appointment during the year Following due process including interview, Dr Charlotte Addy was appointed as Chair of the Workforce and Service Development Committee, and thereby Trustee and will serve for three years, until November 2023. 7.5 The Honorary Secretary will report on plans to replace the Lay Trustee, Alice Joy. 8. Election of members of Council The board agreed in June 2020 to extend the length of service of all members of Council, Standing Committees and Chairs and members of Advisory Groups by a year, so that the hiatus in the work of BTS Committees and related activities would not cause disadvantage to those who would otherwise miss out on almost 6 months of service. An election for members of Council was not therefore necessary this year. 9. BTS Medal and Meritorious Service Award 9.1 BTS Medal The President will award two Medals and recipients will make brief responses: Dr Bernard Higgins Professor John Moxham 9.2 BTS Award for Meritorious Service The President will make this award to Dr David Smith who will make a brief response. 10 Votes of thanks 10.1 To all members of BTS. 10.2 Officers who will stand down at the AGM:- Dr Mohammed Munavvar, President Dr Paul Walker, Honorary Treasurer 4 10.3 Trustees who will stand down at the AGM:- Dr Justine Hadcroft and Dr Graham Wilson, co-Chairs of the Workforce and Service Development Committee 11. Date of next AGM 5.30 pm on Wednesday 24th November 2021. 5 PAPER 1 MINUTES of the meeting of the ANNUAL GENERAL MEETING of the BRITISH THORACIC SOCIETY held on Wednesday 4th December 2019 at the Queen Elizabeth II Conference Centre, Westminster, London SW1P 3EE Dr Mark Elliott presiding. The meeting was quorate, with 62 members attending. 1. Apologies for absence had been received from Dr Ian Campbell, Miss Cassandra Lynch, Dr Rod Lawson, Dr Hazel Morrison, Mr Alan Anderson, Dr Richard Lee and Dr Melissa Wickremasinghe. 2. Minutes of the last meeting (Meeting paper 1) 2.1 The minutes of the Annual General Meeting held on Wednesday 5th December 2018 were confirmed as an accurate record. 3. Matters arising There were no matters arising. 4. Report from the Chair of the Board of Trustees 4.1 The Chair of the BTS Board of Trustees, Professor Jon Bennett, presented a brief report on BTS activities over the past year and summarised the achievements in 2019. He noted that 1 in 6 BTS members plays an active role in the Society for which he and all Trustees were extremely grateful. Professor Bennett emphasised that every activity undertaken by the Society was to help deliver the best outcomes for patients. 4.2 Core activities included the successful Summer and Winter Meetings and the high quality BTS short course programme. The Sumer Meeting had made a surplus for the second year running after 10 years of being in deficit. Professor Bennett noted the Summer Meeting now has a much stronger identity. 4.3 The BTS Guideline for Bronchiectasis in Adults had been published in late 2018 and the BTS/SIGN British Guideline on the Management of Asthma was published in July 2019. Work on further Guidelines continued during the year. The BTS Quality Standards for the Outpatient Management of Pulmonary Embolism was published in October 2019. Several Clinical Statements will be published shortly. It had been another busy year for the Society’s Audit Programme. Adult NIV, Smoking Cessation and Adult CAP audits are all in progress. Professor Bennett acknowledged the enormous amount of work that goes into the Quality Improvement work at BTS and thanked all those involved with this aspect of the Society’s work. 4.4 Respiratory Futures continued to develop. Professor Bennett highlighted what an excellent resource this is for people working is respiratory medicine and encouraged BTS members to promote the site when possible.
Load more

Recommended publications
  • A Bibliometric Analysis
    787 Original Article Page 1 of 9 The 100 most cited articles on lung cancer screening: a bibliometric analysis Meng Li1,2, Qiang Cai2,3, Jing-Wen Ma1, Li Zhang1,2, Claudia I. Henschke2 1Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Radiology, Mount Sinai Health System, New York, NY, USA; 3Department of Radiology, Shanxi Provincial People’s Hospital, Taiyuan, China Contributions: (I) Conception and design: M Li, CI Henschke; (II) Administrative support: CI Henschke; (III) Provision of study materials or patients: M Li, CI Henschke; (IV) Collection and assembly of data: M Li, L Zhang; (V) Data analysis and interpretation: M Li, Q Cai, JW Ma; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Claudia I. Henschke. Department of Radiology, Mount Sinai Health System, 1 Gustave Levy Place, New York, NY 10029, USA. Email: [email protected]. Background: The number of citations of an article reflects its impact on the scientific community. The aim of this study was to identify and characterize the 100 most cited articles on lung cancer screening. Methods: The 100 most cited articles on lung cancer screening published in all scientific journals were identified using the Web of Science database. Relevant data, including the number of citations, publication year, publishing journal and impact factor (IF), authorship and country of origin, article type and study design, screening modality, and main topic, were collected and analyzed. Results: The 100 most cited articles were all English and published between 1973 and 2017, with 81 published after 2000.
    [Show full text]
  • Scientific Publications in Respiratory Journals from Chinese
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2013-004201 on 28 February 2014. Downloaded from Scientific publications in respiratory journals from Chinese authors in various parts of North Asia: a 10-year survey of literature Bo Ye,1 Ting-Ting Du,1 Ting Xie,2 Jun-Tao Ji,1 Zhao-Hong Zheng,1 Zhuan Liao,1 Liang-Hao Hu,1 Zhao-Shen Li1 To cite: Ye B, Du T-T, Xie T, ABSTRACT et al Strengths and limitations of this study . Scientific publications in Objectives: Respiratory disease remains one of the respiratory journals from leading causes of morbidity and mortality in China. Chinese authors in various A few journals covered resources beyond respiratory However, little is known about the research status of parts of North Asia: a 10-year even selected from the respiratory system of Science — survey of literature. BMJ Open respirology in three major regions of China Mainland Citation Index Expanded (SCIE). Besides, some 2014;4:e004201. doi:10.1136/ (ML), Hong Kong (HK) and Taiwan (TW). A 10-year related journals not shown in SCIE were not col- bmjopen-2013-004201 survey of literature was conducted to compare the lected. Some respiratory medicine research articles three regions’ outputs in the research of respirology. were published in general journals, rather than in the ▸ Prepublication history for Design: A bibliometric study. specialized ones. Searching by the author’s address this paper is available online. Setting: China. (China, HK or TW) led to another problem that the To view these files please Participants and outcome measures: A literature articles which addressed other cities or provinces visit the journal online search in PubMed database, updated as of September were not included.
    [Show full text]
  • Expanding Access in High-Quality Respiratory and Critical Care Medicine Research: BMJ Open Respiratory Research
    Editorial BMJ Open Resp Res: first published as 10.1136/bmjresp-2013-000003 on 3 October 2013. Downloaded from Expanding access in high-quality respiratory and critical care medicine research: BMJ Open Respiratory Research Stephen J Chapman,1 Matt P Wise2 To cite: Chapman SJ, We are delighted to introduce BMJ Open rather than its perceived potential impact. We Wise MP. Expanding access Respiratory Research, an online peer-reviewed are interested in publishing all research study in high-quality respiratory and critical care medicine open access respiratory medicine journal pub- types, including small or specialist studies, BMJ research: BMJ Open Resp lished by the in partnership with the important negative results, and replication Res 2013;1:e000003. British Thoracic Society. The journal is dedicated studies, with the aim of adding to the overall doi:10.1136/bmjresp-2013- to rapid publication of high-quality research body of knowledge available in the public 000003 from all areas of respiratory medicine, includ- domain. We envisage that readers and the ing respiratory science and critical care. wider respiratory research community will Publication bias and a preoccupation with determine the impact of published research Accepted 13 August 2013 journal impact factor mean that currently avail- articles on an individual basis, and in order to able research findings in respiratory medicine encourage this we will provide article-level arelikelytorepresentonlythe‘tip of the metrics including counts of views and citations. iceberg’, with many more preliminary, The journal will maximise visibility of authors’ small-scale or negative studies remaining research by ensuring free online access to a copyright.
    [Show full text]
  • British Thoracic Society Winter Meeting
    February 2021 Volume 76 Supplement 1 76 S1 Volume 76 Supplement 1 Pages A1–A256 ThoraxAN INTERNATIONAL JOURNAL OF RESPIRATORY MEDICINE British Thoracic Society THORAX Winter Meeting Wednesday 17 to Friday 19 February 2021 Programme and Abstracts February 2021 February thorax.bmj.com PROGRAMME AND Thorax ABSTRACTS British Thoracic Society Winter Meeting Wednesday 17 to Friday 19 February 2021 Programme and Abstracts Approved by the Federation of the Royal Colleges of Physicians of the UK for 18 category I (external) credits (6 credits per day). Code: 133787 DAILY PROGRAMME WEDNESDAY 17 FEBRUARY 2021 All Symposia, Guest Lectures, Journal Clubs and Spoken Sessions will be shown online live at the times below, and will be available to view via the relevant ‘session type’ tab online. Poster presentations will be pre-recorded and available on demand each day and should be viewed prior to the Poster Discussion Q&A, which will be online live at the times below, all via the ‘Poster Sessions’ tab. Time Session Type Session Title 7.00am – 6.00pm Poster viewing on demand P1-P11 Lessons from COVID-19 throughout the day with live P12-P24 Lung cancer: treatment options and care pathways discussions at the programmed P38-P51 COPD: clinical science times P63-P75 Primary care and paediatric asthma P76-P88 Virtually systematic: current interventions and digital delivery in pulmonary rehabilitation 7.45am – 8.00am Symposium Daily preview 8.00am – 8.30am BTS Journal Club New insights to chronic cough 8.30am – 10.00am Symposium Neutrophilic asthma 8.30am –
    [Show full text]
  • Evaluation of Oxidative Stress Biomarkers in Idiopathic Pulmonary Fibrosis and Therapeutic Applications: a Systematic Review Alessandro G
    Fois et al. Respiratory Research (2018) 19:51 https://doi.org/10.1186/s12931-018-0754-7 REVIEW Open Access Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review Alessandro G. Fois1,2*†, Panagiotis Paliogiannis3†, Salvatore Sotgia3, Arduino A. Mangoni4, Elisabetta Zinellu2, Pietro Pirina1,2, Ciriaco Carru3 and Angelo Zinellu3 Abstract Introduction: Idiopathic pulmonary fibrosis (IPF), a fatal lung disease of unknown origin, is characterized by chronic and progressive fibrosing interstitial pneumonia which progressively impairs lung function. Oxidative stress is one of the main pathogenic pathways in IPF. The aim of this systematic review was to describe the type of markers of oxidative stress identified in different biological specimens and the effects of antioxidant therapies in patients with IPF. Methods: We conducted a systematic search of publications listed in electronic databases (Pubmed, Web of Science, Scopus and Google Scholar) from inception to October 2017. Two investigators independently reviewed all identified articles to determine eligibility. Results: After a substantial proportion of the initially identified articles (n = 554) was excluded because they were duplicates, abstracts, irrelevant, or did not meet the selection criteria, we identified 30 studies. In each study, we critically appraised the type, site (systemic vs. local, e.g. breath, sputum, expired breath condensate, epithelial lining fluid, bronchoalveolar lavage, and lung tissue specimens), and method used for measuring the identified oxidative stress biomarkers. Furthermore, the current knowledge on antioxidant therapies in IPF was summarized. Conclusions: A number of markers of oxidative stress, with individual advantages and limitations, have been described in patients with IPF.
    [Show full text]
  • The Ambition of the European Respiratory Journal: Chapter 4
    EDITORIAL | THE AMBITION OF THE ERJ The ambition of the European Respiratory Journal: chapter 4 Marc Humbert1, Anh Tuan Dinh-Xuan2, Elin L. Reeves3, Matthew G. Broadhead3 and Neil J. Bullen3 Affiliations: 1Service de Pneumologie, University Paris-Sud, Inserm U999, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 2Service de Physiologie, Paris Descartes University EA 2511, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France. 3European Respiratory Society Publications Office, Sheffield, UK. Correspondence: Marc Humbert, Service de Pneumologie, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France. E-mail: [email protected] @ERSpublications The ERJ: publishing and contextualising the best in respiratory research and practice http://ow.ly/V1Gsd Already we are more than half-way through the current 5-year editorial cycle of the European Respiratory Journal (ERJ), and as we begin 2016 we again open our first issue of the new year with our annual round up and look to the future. Traditionally, the ERJ has been founded on exceptionally strong research content, attracting the most important, cutting-edge and novel original material from all over the world, and delivering this content to all corners of the globe; in 2015 alone we will have published 200 original research articles encompassing the full spectrum of respiratory diseases. However, we also increasingly seek to provide context to this material and enhance it as much as possible for our readers with editorial comment and discussion through correspondence. We are proud to see that the Agora section continues to develop, both augmenting our research content with short reports and also framing it with thought-provoking and perceptive correspondence, and hopefully bringing our readers to this notional meeting place so that they can participate in the discussion themselves.
    [Show full text]
  • BMJ Open Respiratory Research: 1 Year On
    Downloaded from http://bmjopenrespres.bmj.com/ on October 4, 2015 - Published by group.bmj.com Editorial BMJ Open Respiratory Research: 1 year on Matt P Wise,1 Stephen J Chapman2 To cite: Wise MP, BMJ Open Respiratory Research is now entering its satisfied with the publishing process and how BMJ Open Chapman SJ. second year as an open access journal. Our the journal is taking shape. We are delighted Respiratory Research: 1 year on. BMJ Open Resp aim when the journal was launched was to that the contents are now listed on PubMed, Res 2015;2:e000077. facilitate the rapid publication of high-quality andwehopethiswillincreasetheattractiveness doi:10.1136/bmjresp-2014- research from all areas of respiratory medicine for potential authors as well as increase visibility 000077 including respiratory science and critical care.1 of the journal’s content. Although much is As an open access periodical, we have the rightly made of the advantages of open access opportunity to limit publication bias by pub- publishing in terms of unrestricted ease of Received 29 December 2014 lishing studies that other journals may not access to the medical and scientific community, Accepted 2 January 2015 favour due to a perceived lack of importance an additional positive consequence is the wide- or impact. Our aspiration has been to focus on spread accessibility of medical research to well-conducted studies that acknowledge and patients. Indeed, the journal’smostdown- discuss potential limitations when they exist. loaded article to date is a qualitative study of Unfortunately, too many small-scale, prelimin- caregivers’ experiences of idiopathic pulmon- ary, negative, repeat or observational studies, ary fibrosis,2 an insightful article that has been which could usefully contribute to the promoted in part by patient foundations, and research landscape, fail to reach publication.
    [Show full text]
  • Paper Acceptance Time in Respiratory Research: Room for Improvement?
    AGORA | RESEARCH LETTER Paper acceptance time in respiratory research: room for improvement? To the Editor: We recently submitted a paper to a top five respiratory journal in terms of average citations per article. The paper was swiftly sent for peer review. A month later, the review was in, and the paper was now “awaiting associate editor decision”. After another 6 weeks, and at the time of writing this letter, the paper is still with the handling editor. Like us, many authors have probably at this stage speculated when it would be reasonable to contact the editorial office and enquire about the status. A recent study carried out for Nature showed that the median time between submission and acceptance of a paper for 4375 different journals was approximately 100 days [1, 2]. The study was based on an analysis of all papers in PubMed for which these data were listed from 1965 to 2015 and included more than 6 million observations of acceptance and publication time. Somewhat surprisingly, the acceptance time has remained fairly constant for more than 30 years and may in fact underestimate the actual time, as not all journals choose to deposit these data. Moreover, some journals use the re-submission date rather than the date for initial submission as the “start date”, which may also bias the results. Based on this large dataset at hand, available on GitHub [2], it is possible to analyse acceptance time for most respiratory journals. If the analysis is restricted to those respiratory journals with more than three citations per paper over 2 years, of which there are 22 journals [3], 18820 papers are found with reported acceptance times.
    [Show full text]
  • Top 20 Journals Relevant to Overall Health Care Services Ranked by Impact Factor
    The following lists of journals have been provided as a resource to assist the Quality Improvement community in identifying high impact journals, and journals influential in specific topic areas relevant to QI efforts within health care. Identified journals publish papers by both traditional and open access publication processes. Top 20 journals relevant to overall health care services ranked by impact factor: Journal Name Impact Factor CA-A CANCER JOURNAL FOR CLINICIANS (supports open access) 137.578 NEW ENGLAND JOURNAL OF MEDICINE 59.558 LANCET (supports open access) 44.002 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 37.684 NATURE MEDICINE 30.357 NATURE REVIEWS NEUROSCIENCE 29.298 LANCET ONCOLOGY (supports open access) 26.509 LANCET INFECTIOUS DISEASES (supports open access) 21.372 JOURNAL OF CLINICAL ONCOLOGY (supports open access) 20.982 BMJ-BRITISH MEDICAL JOURNAL (supports open access) 19.697 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (supports open access) 17.759 CIRCULATION (supports open access) 17.202 ANNALS OF INTERNAL MEDICINE 16.593 LANCENT DIABETES & ENDOCRINOLOGY (supports open access) 16.32 JAMA PSYCHIATRY 14.417 JAMA INTERNAL MEDICINE 14.00 PLOS MEDICINE (open access) 13.585 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 13.118 INTENSIVE CARE MEDICINE (supports open access) 10.125 Top 20 journals relevant to quality improvement in health care ranked by impact factor: Journal Name Impact Factor NEW ENGLAND JOURNAL OF MEDICINE 59.558 LANCET (supports open access) 44.002 JAMA-JOURNAL OF THE AMERICAN MEDICAL
    [Show full text]
  • Bts Guideline for Oxygen Use in Adults in Healthcare And
    June 2017 Volume 72 Supplement 1 72 S1 Volume 72 Supplement 1 Pages i1–i90 ThoraxAN INTERNATIONAL JOURNAL OF RESPIRATORY MEDICINE BTS GUIDELINE FOR OXYGEN USE THORAX IN ADULTS IN HEALTHCARE AND EMERGENCY SETTINGS British Thoracic Society Emergency Oxygen Guideline Development Group June 2017 thorax.bmj.com thoraxjnl_72_S1_Cover.indd 1 10/05/17 5:31 PM Endorsements Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer. thoraxjnl_72_S2_Title_Page.indd 2 11/05/17 6:51 PM BTS Emergency Oxygen Guideline Development Group B Ronan O’Driscoll, Luke Howard, John Earis, Vince Mak, Sabrina Bajwah, Richard Beasley, Katrina Curtis, Anthony Davison, Alistair Dorward, Chris Dyer, Angela Evans, Lucy Falconer, Clare Fitzpatrick, Simon Gibbs, Kim Hinshaw, Robin Howard, Binita Kane, Jeff Keep, Carol Kelly, Hasanin Khachi, Muhammed Asad Iqbal Khan, Roop Kishen, Leigh Mansfi eld, Bruce Martin, Fionna Moore, Duncan Powrie, Louise Restrick, Christine Roffe, Mervyn Singer, Jasmeet Soar, Iain Small, Lisa Ward, David Whitmore, Wisia Wedzicha, Meme Wijesinghe British Thoracic Society Emergency Oxygen Guideline Development Group On behalf
    [Show full text]
  • Bibliometric Analysis of Ongoing Projects: Innovative Medicines Initiative Joint Undertaking (IMI)
    Bibliometric analysis of ongoing projects: Innovative Medicines Initiative Joint Undertaking (IMI) IMI EXECUTIVE OFFICE Fourth report: April 2014 Prepared by Thomson Reuters on behalf of IMI JU Executive Office under a public procurement procedure Copyright IMI JU April 2014 Disclaimer/Legal Notice: This document and attachments have been prepared solely for the Innovative Medicines Initiative Joint Undertaking (IMI JU). All contents may not be re-used (in whatever form and by whatever medium) by any third party without prior permission of the IMI JU. 2 Copyright IMI JU April 2014 1 Executive Summary .......................................................................................................................... 5 2 Introduction ....................................................................................................................................... 9 2.1 Overview ................................................................................................................................. 9 2.2 Innovative Medicines Initiative Joint Undertaking (IMI) .......................................................... 9 2.3 Thomson Reuters ................................................................................................................... 9 2.4 Thomson Reuters Research Analytics ................................................................................. 10 2.5 Thomson Reuters Custom Analytics & Engineered Solutions ............................................. 10 2.6 Scope of this report ..............................................................................................................
    [Show full text]
  • BTS Guideline for Bronchiectasis in Adults Has Been Endorsed By
    January 2019 Volume 74 Supplement 1 AnThorax international journal of RESPIRATORY MEDICINE BRITISH THORACIC SOCIETY GUIDELINE FOR BRONCHIECTASIS IN ADULTS British Thoracic Society Bronchiectasis in Adults Guideline Development Group thorax.bmj.com BTS Bronchiectasis in Adults Guideline Development Group Professor Adam T Hill, Dr Anita L Sullivan, Professor James D Chalmers, Professor Anthony De Soyza, Professor J Stuart Elborn, Professor R Andres Floto, Ms Lizzie Grillo, Dr Kevin Gruffydd-Jones, Ms Alex Harvey, Dr Charles S Haworth, Mr Edwin Hiscocks, Dr John R Hurst, Dr Christopher Johnson, Dr W Peter Kelleher, Dr Pallavi Bedi, Miss Karen Payne, Mr Hesham Saleh, Dr Nicholas J Screaton, Dr Maeve Smith, Professor Michael Tunney, Dr Deborah Whitters, Professor Robert Wilson, Professor Michael R Loebinger On behalf of the British Thoracic Society The BTS Guideline for Bronchiectasis in Adults has been endorsed by: Association for Chartered Physiotherapists in Respiratory Care Association of Respiratory Nurse Specialists Primary Care Respiratory Society UK Royal College of Physicians London Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient
    [Show full text]